Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 131 | AMN Healthcare Services Inc (AMN) | XNYS | US | 2024-12-31 | 1 day ago | USD | 20.30 | 39.85 | 196.32% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 132 | Accenture PLC (ACN) | XNYS | IE | 2025-08-31 | 1 day ago | USD | 240.62 | 113.67 | 47.24% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 133 | ACNB Corp (ACNB) | XNAS | US | 2025-12-31 | 5 days ago | USD | 52.20 | 57.93 | 110.97% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 134 | Acorda Therapeutics Inc (ACOR) | XNAS | US | 2022-12-31 | 1 year ago | USD | 1.35 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 135 | Ares Commercial Real Estate Corp (ACRE) | XNYS | US | 2024-12-31 | 1 day ago | USD | 5.20 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 136 | Ameriprise Financial Inc (AMP) | XNYS | US | 2025-12-31 | 1 day ago | USD | 542.99 | 224.00 | 41.25% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 137 | AcelRx Pharmaceuticals Inc (ACRX) | XNAS | US | 2022-12-31 | 2 years ago | USD | 0.99 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 138 | Alexion Pharmaceuticals Inc (ALXN) | 2020-12-31 | 4 years ago | USD | 182.50 | 73.25 | 40.14% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% | ||
| 139 | Amcor PLC (AMCR) | XNYS | CH | 2025-06-30 | 1 day ago | USD | 48.17 | 151.79 | 315.11% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 140 | Adaptimmune Therapeutics PLC (ADAP) | XNAS | GB | 2024-12-31 | 3 months ago | USD | 0.06 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |